BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16850327)

  • 1. Effects of single doses of rabeprazole 20 mg and esomeprazole 40 mg on 24-h intragastric pH in healthy subjects.
    Warrington S; Baisley K; Dunn K; Boyce M; Morocutti A
    Eur J Clin Pharmacol; 2006 Sep; 62(9):685-91. PubMed ID: 16850327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined analysis of three crossover clinical pharmacology studies of effects of rabeprazole and esomeprazole on 24-h intragastric pH in healthy volunteers.
    Norris V; Baisley K; Dunn K; Warrington S; Morocutti A
    Aliment Pharmacol Ther; 2007 Feb; 25(4):501-10. PubMed ID: 17270006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects.
    Warrington S; Baisley K; Boyce M; Tejura B; Morocutti A; Miller N
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1301-7. PubMed ID: 12144580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of esomeprazole and rabeprazole on intragastric pH in healthy Chinese: an open, randomized crossover trial.
    Li ZS; Zhan XB; Xu GM; Cheng NN; Liao Z
    J Gastroenterol Hepatol; 2007 Jun; 22(6):815-20. PubMed ID: 17565634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers.
    Wilder-Smith CH; Röhss K; Nilsson-Pieschl C; Junghard O; Nyman L
    Digestion; 2003; 68(4):184-8. PubMed ID: 14691345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects.
    Williams MP; Sercombe J; Hamilton MI; Pounder RE
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1079-89. PubMed ID: 9845397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic effects of single doses of rabeprazole 20 mg and pantoprazole 40 mg in patients with GERD and nocturnal heartburn.
    Warrington S; Baisley K; Lee D; Lomax K; Delemos B; Boyce M; Morocutti A
    Aliment Pharmacol Ther; 2007 Feb; 25(4):511-7. PubMed ID: 17270007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.
    Röhss K; Lind T; Wilder-Smith C
    Eur J Clin Pharmacol; 2004 Oct; 60(8):531-9. PubMed ID: 15349707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative effectiveness of the antisecretory action of rabeprazole and esomeprazole in people with rapid metabolism of proton pump inhibitors].
    Morozov SV; Tsodikova OM; Isakov VA; Gushchin AE; Shipulin GA
    Eksp Klin Gastroenterol; 2003; (6):58-63, 154. PubMed ID: 15065530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of single and repeated oral doses of lansoprazole and rabeprazole on ambulatory 24-hour intragastric pH in healthy volunteers.
    Tolman KG; Täubel J; Warrington S; Chiu YL; Pilmer BL; Pan WJ
    Clin Drug Investig; 2006; 26(1):21-8. PubMed ID: 17163231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intragastric acidity after switching from 5-day treatment with intravenous pantoprazole 40 mg/d to 5-day treatment with oral esomeprazole 40 mg/d or pantoprazole 40 mg/d: an open-label crossover study in healthy adult volunteers.
    Miner PB; Tutuian R; Castell DO; Liu S; Sostek MB
    Clin Ther; 2006 May; 28(5):725-33. PubMed ID: 16861094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label, parallel, multiple-dose study comparing the pharmacokinetics and gastric acid suppression of rabeprazole extended-release with esomeprazole 40 mg and rabeprazole delayed-release 20 mg in healthy volunteers.
    Morelli G; Chen H; Rossiter G; Rege B; Lu Y
    Aliment Pharmacol Ther; 2011 Apr; 33(7):845-54. PubMed ID: 21272047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
    Miner P; Katz PO; Chen Y; Sostek M
    Am J Gastroenterol; 2003 Dec; 98(12):2616-20. PubMed ID: 14687806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, pharmacodynamics, and safety of esomeprazole injection/infusion in healthy Chinese volunteers: a five-way crossover study.
    Yang H; Li J; Zhao Q; Li J; Shen K; Yang X; Jiang J; Hu P; Qian J
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1823-8. PubMed ID: 23800161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism.
    Hunfeld NG; Touw DJ; Mathot RA; van Schaik RH; Kuipers EJ
    Aliment Pharmacol Ther; 2012 Apr; 35(7):810-8. PubMed ID: 22324425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravenous esomeprazole 40 mg and pantoprazole 40 mg on intragastric pH in healthy subjects. A prospective, open, randomised, two-way cross-over comparative study.
    Piccoli F; Ory G; Hadengue A; Beglinger C; Degen L
    Arzneimittelforschung; 2007; 57(10):654-8. PubMed ID: 18074759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the pharmacokinetics and intragastric pH of rabeprazole given as successive intravenous infusion to healthy Chinese volunteers.
    Wang Y; Yuan Y; Meng L; Fan H; Xu J; Zhang H; Wang M; Yuan H; Ou N; Zhang H; Chao Y; Shi R
    Eur J Clin Pharmacol; 2011 Jan; 67(1):25-31. PubMed ID: 21110014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily--a randomized, two-way crossover study.
    Miehlke S; Madisch A; Kirsch C; Lindner F; Kuhlisch E; Laass M; Knoth H; Morgner A; Labenz J
    Aliment Pharmacol Ther; 2005 Apr; 21(8):963-7. PubMed ID: 15813831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects.
    Williams MP; Blanshard C; Millson C; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 2000 Jun; 14(6):691-9. PubMed ID: 10848651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A glass of water immediately increases gastric pH in healthy subjects.
    Karamanolis G; Theofanidou I; Yiasemidou M; Giannoulis E; Triantafyllou K; Ladas SD
    Dig Dis Sci; 2008 Dec; 53(12):3128-32. PubMed ID: 18473176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.